MedTrace Logo

The Effect of Octreotide on Wound Drainage After Mastectomy

NCT05682209 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2023-01-18

No results posted yet for this study

Summary

Patients who had mastectomy for breast cancer usually have drainage of some fluid from the site of surgery. This could be prolonged and may lead to other negative consequences after surgery. Octreotide could potentially reduce the amount of this drainage. In this study, patients were grouped into two: a first group that received octreotide injection and a second group that received a placebo. The study tested whether octreotide injection has any effect on the duration of fluid drainage from the surgery site after mastectomy for breast cancer.

Conditions

  • Seroma Following Procedure

Interventions

DRUG

Octreotide Injection

100µg of octreotide intravenously 8-hourly for 5 days from the first post-operative day

OTHER

Sterile water

1ml of sterile water intravenously 8-hourly for 5 days from the first post-operative day

Sponsors & Collaborators

  • Ikechukwu Bartholomew Ulasi

    lead OTHER

Principal Investigators

  • Ikechukwu B. Ulasi · University College Hospital, Ibadan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-18
Primary Completion
2021-11-15
Completion
2021-12-02

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05682209 on ClinicalTrials.gov